| Financial Year |
March 31 2023 |
| Monetary Funds |
983,429,195.93 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
19,542,883.41 |
| Accounts Receivable |
1,248,582,370.39 |
| Advances to Suppliers |
625,103,591.00 |
| Other Receivables |
33,943,598.20 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
823,867,876.33 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
25,371,151.23 |
| Total Current Assets |
4,200,334,442.17 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
896,854.65 |
| Investment Properties |
-- |
| Fixed Assetes |
157,799,378.28 |
| Under-construction Projects |
25,350,566.02 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
34,649,489.19 |
| R&D expenses |
2,485,436.90 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
2,955,473.87 |
| Deferred Income Tax Assets |
83,284,129.50 |
| Other Non-Current Assets |
66,641,170.93 |
| Sub-Total of Non-Current Assets |
558,377,397.51 |
| Total Assets |
4,758,711,839.68 |
| Short-Term Loans |
1,132,200,181.17 |
| Trading Financial liabilities |
-- |
| Notes Payable |
66,755,506.25 |
| Accounts Payable |
653,164,468.29 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
24,086,273.27 |
| Taxes Payable |
71,529,848.50 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
19,330,481.41 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
190,400,000.00 |
| Other Current Liabilities |
20,526,487.69 |
| Sub-Total of Current Liabilities |
2,436,608,093.99 |
| Long-term Loans |
458,500,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
51,031,045.74 |
| Other Non-Current Liabilities |
6,064,441.84 |
| Sub-Total of Non-Current Liabilities |
708,333,290.02 |
| Total Liabilities |
3,144,941,384.01 |
| Paid-In Capital(Or Share Stock) |
143,178,622.00 |
| Capital Surplus |
1,006,133,825.61 |
| Surplus Reserve |
40,568,740.74 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
412,341,098.26 |
| Minority Stockholder's Interest |
11,548,169.06 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,602,222,286.61 |
| Owner's Equity（Stockholder's Equity） |
1,613,770,455.67 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,758,711,839.68 |
